Ewa Szczepulska-Wójcik

Summary

Affiliation: National Institute of Tuberculosis and Lung Diseases
Country: Poland

Publications

  1. ncbi [Malignant pleural mesothelioma--histopathological classification, staging and microscopic diagnosis]
    Szczepulska Wójcik Ewa
    Zakład Patomorfologii, Instytutu Gruźlicy i Chorób Płuc, Warszawie
    Pneumonol Alergol Pol 73:285-91. 2005
  2. ncbi [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation]
    Ewa Szczepulska-Wójcik
    Zakład Patomorfologii Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pneumonol Alergol Pol 75:57-69. 2007
  3. ncbi Pulmonary epithelioid haemangioendothelioma--interferon 2-alpha treatment--case report
    Elzbieta Radzikowska
    National Tuberculosis and Lung Diseases Research Institute, Plocka Street 26, Warsaw, Poland
    Pneumonol Alergol Pol 76:281-5. 2008

Collaborators

Detail Information

Publications3

  1. ncbi [Malignant pleural mesothelioma--histopathological classification, staging and microscopic diagnosis]
    Szczepulska Wójcik Ewa
    Zakład Patomorfologii, Instytutu Gruźlicy i Chorób Płuc, Warszawie
    Pneumonol Alergol Pol 73:285-91. 2005
  2. ncbi [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation]
    Ewa Szczepulska-Wójcik
    Zakład Patomorfologii Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pneumonol Alergol Pol 75:57-69. 2007
    ..The objective of this study was to evaluate the significance of selected immunohistochemical stains in differentiating MM from non-small cell lung cancers infiltrating the pleura and from benign reactive mesothelial cell proliferation...
  3. ncbi Pulmonary epithelioid haemangioendothelioma--interferon 2-alpha treatment--case report
    Elzbieta Radzikowska
    National Tuberculosis and Lung Diseases Research Institute, Plocka Street 26, Warsaw, Poland
    Pneumonol Alergol Pol 76:281-5. 2008
    ..Interferon alpha treatment was introduced. During the therapy, a slight regression of pulmonary changes was noticed and since then stabilization of the disease was observed...